Alaffia Health, a company that specialises in generative AI for health plan claim operations secures $10million in funding.
FirstMark Capital led the round, and GingerBread Capital and current investors Anthemis, Aperture Venture Capital, 1984 Ventures, Remarkable Ventures, and Tau Ventures also participated. Amish Jani from FirstMark will become a member of Alaffia’s board of directors in relation to the financing.
With the money, the firm hopes to increase its commercial footprint and make further investments in cutting-edge AI research and product development. Alaffia Health is an AI startup that assists health insurance companies in streamlining their operations and cutting down on claim costs. TJ Ademiluyi serves as the company’s CEO.
Read also – CA-based Anvilogic Secures $45Million in Series C Round Funding
The business provides Autodor, a co-pilot designed for teams handling health insurance claims. With Autodor, medical coders and clinicians may analyse health insurance claims in the areas of appeals, special investigations, payment integrity, and utilisation management.
About Alaffia Health
Alaffia Health is a healthtech startup that employs artificial intelligence (AI) to lower claim expenditure and operational expenses for cost containment companies and healthcare payers. In order to assist our clients ingest, analyse, and process healthcare claims as effectively as possible, they offer them their comprehensive claim review SaaS platform, Autodor.
